Gestational Weight Gain Following Metabolic Bariatric Surgery: A Scoping Review.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
01 Aug 2024
Historique:
received: 04 07 2024
revised: 26 07 2024
accepted: 29 07 2024
medline: 10 8 2024
pubmed: 10 8 2024
entrez: 10 8 2024
Statut: epublish

Résumé

Metabolic bariatric surgery remains the most effective and durable treatment for severe obesity. Women of reproductive age represent the largest demographic group undergoing these procedures. Metabolic bariatric surgery can have both beneficial and adverse effects on pregnancy outcomes. One of the most common adverse effects is fetal growth restriction. To mitigate these adverse effects, it is crucial to explore lifestyle modifications aimed at promoting a healthy pregnancy. Modifiable factors during pregnancy after metabolic bariatric surgery include the amount of gestational weight gain. The aim of this comprehensive review is to provide an overview of what is known about gestational weight gain in pregnancy after bariatric metabolic surgery. This review is focused on the two most performed procedures: sleeve gastrectomy and Roux-en-Y gastric bypass.

Identifiants

pubmed: 39125396
pii: nu16152516
doi: 10.3390/nu16152516
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Ellen Deleus (E)

Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium.
Department of Abdominal Surgery, University Hospitals Leuven, 3000 Leuven, Belgium.

Matthias Lannoo (M)

Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium.
Department of Abdominal Surgery, University Hospitals Leuven, 3000 Leuven, Belgium.

Dries Ceulemans (D)

Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.
Department of Obstetrics and Gynecology, University Hospitals Leuven, 3000 Leuven, Belgium.

Roland Devlieger (R)

Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.
Department of Obstetrics and Gynecology, University Hospitals Leuven, 3000 Leuven, Belgium.

Bart Van der Schueren (B)

Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium.
Department of Endocrinology, University Hospitals Leuven, 3000 Leuven, Belgium.

Katrien Benhalima (K)

Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium.
Department of Endocrinology, University Hospitals Leuven, 3000 Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH